|
Analysis: The goal of this fund is to produce capital gains over time by investing in companies with good growth potential. So it should come as no great surprise that biotech heavyweight Genentech tops the list of holdings with almost 6% of the portfolio weighting. Information technology stocks are the largest asset group at 27.5% of the portfolio. Interestingly, energy stocks aren’t even a blip on the manager’s radar screen despite the soaring price of oil and natural gas. So far, the fund has done well for investors. The three-year average annual compound rate of return of 6.8% is almost double the category average, as is the one-year advance of 12.4%. All that IT exposure could spell trouble down the road and we wonder at the lack of energy stocks but you can’t argue with success. Debuts at $$$.